This document is an excerpt from the EUR-Lex website
Document 62021TN0370
Case T-370/21: Action brought on 30 June 2021 — Biogena v EUIPO — Alter Farmacia (NUTRIFEN AGNUBALANCE)
Case T-370/21: Action brought on 30 June 2021 — Biogena v EUIPO — Alter Farmacia (NUTRIFEN AGNUBALANCE)
Case T-370/21: Action brought on 30 June 2021 — Biogena v EUIPO — Alter Farmacia (NUTRIFEN AGNUBALANCE)
OJ C 329, 16.8.2021, pp. 40–40
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
16.8.2021 |
EN |
Official Journal of the European Union |
C 329/40 |
Action brought on 30 June 2021 — Biogena v EUIPO — Alter Farmacia (NUTRIFEN AGNUBALANCE)
(Case T-370/21)
(2021/C 329/53)
Language of the case: English
Parties
Applicant: Biogena GmbH & Co KG (Salzburg, Austria) (represented by: I. Schiffer, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Alter Farmacia, SA (Madrid, Spain)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Applicant before the General Court
Trade mark at issue: International registration designating the European Union in respect of the word mark NUTRIFEN AGNUBALANCE — International registration designating the European Union No 1 430 349
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 22 April 2021 in Case R 1208/2020-5
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
grant the registration of the IR 1 430 349 for all applied goods; |
|
— |
order EUIPO and Alter Farmacia, S. A. to pay the costs. |
Pleas in law
|
— |
Infringement of Article 8 (1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
|
— |
Infringement of Article 94 of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |